Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Jan
12
2021
2020 Advertising Law Year in Review Proskauer Rose LLP
Feb
6
2020
2020 Digital Health Outlook: Thoughts from CES and JPM [Podcast] McDermott Will & Emery
Nov
30
2020
2020 DOJ Health Care Fraud Takedown Greenberg Traurig, LLP
Aug
28
2019
2020 Drug Coupon Rule Dropped Due to Implementation Concerns Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Jan
13
2020
2020 Starts Off With Two Government Publications Critical Of 340B Program Oversight McDermott Will & Emery
Oct
18
2022
2022 Chemicals Workshop Webinar Series: TSCA Developments and US EPA Updates Squire Patton Boggs (US) LLP
Aug
13
2022
2022 Liquor Liability Laws – A 50-State Survey Wilson Elser Moskowitz Edelman & Dicker LLP
Feb
4
2022
2022 Mental Health Parity Report to Congress Highlights Increased Enforcement Efforts Epstein Becker & Green, P.C.
Nov
10
2022
2022 Midterm Elections Early Results: Control of Congress; Minimum Wage, and Legalized Marijuana Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Dec
1
2022
2022 Midterms and the Future of the Safe Banking Act Bradley Arant Boult Cummings LLP
Oct
7
2022
2022 National Youth Tobacco Survey Indicates Modest Increase in Youth Vaping Rates Keller and Heckman LLP
Jan
6
2023
2022 TTB Industry Circular 1: Consignment Sales McDermott Will & Emery
Jan
6
2023
2022 TTB Industry Circular 2: Social Media Advertising McDermott Will & Emery
Jan
3
2023
2022, Who Were You? A Recap of Hot Issues in 2022. Bradley Arant Boult Cummings LLP
Jan
26
2023
2023 Federal Forecast – Agriculture ArentFox Schiff LLP
Feb
26
2024
2023 Health Care Employment Law Year in Review K&L Gates
Jan
9
2023
2023 Labor and Employment Outlook for Manufacturers Robinson & Cole LLP
Nov
6
2023
2023 National Youth Tobacco Survey Shows Significant Decline in High School Vaping Keller and Heckman LLP
Feb
5
2024
2023 Retail Industry Year in Review Hunton Andrews Kurth
Aug
21
2023
2023 Update on Alabama Alcohol Laws Bradley Arant Boult Cummings LLP
Jan
4
2024
2023: A Good Trip Around the Sun for Psychedelics Bradley Arant Boult Cummings LLP
Dec
20
2023
2023: Another Year Chock Full of Challenges for FDA Mintz
Apr
30
2024
2024 Florida Alcoholic Beverage Legislation Recap Jones Walker LLP
Mar
20
2024
2024 Litigation Look Ahead Series: Key Cases That Could Impact CERCLA Liability and Contribution Claims Beveridge & Diamond PC
Jan
29
2024
2024 Top-of-Mind Issues for Life Sciences Companies Sheppard, Mullin, Richter & Hampton LLP
Mar
16
2017
21st Century Cures Act Developments: FDA Proposes Class II Device Exemptions Mintz
Dec
16
2016
21st Century Cures Act Grants Additional Grandfathered Status to Some Off-Campus Hospital Outpatient Departments Faegre Drinker
Dec
15
2016
21st Century Cures Act’s Effect on Pharmaceutical and Biotechnology Industries Morgan, Lewis & Bockius LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins